Jenne Kyle

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Jenne Kyle's trades of Ionis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-17 2026-04-16
S Sale
29,801 -1.9%
330.10
US$4,642,821 		29,801 -1.9% 330.10 US$4,642,821
2026-04-16 2026-04-16
PrS Proposed sale
40,385
160.66
US$4,545,041 		40,385 160.66 US$4,545,041
2026-03-11 2026-03-10
PlS Planned sale
68,780 -40.7%
342.65
US$4,836,316 		68,780 -40.7% 342.65 US$4,836,316
2026-03-11 2026-03-10
PlS Planned sale
21,191 -43.3%
75.50
US$1,599,963 		21,191 -43.3% 75.50 US$1,599,963
2026-03-10 2026-03-10
PrS Proposed sale
58,253
75.57
US$4,402,296 		58,253 75.57 US$4,402,296
2026-01-20 2026-01-16
S Sale
1,823 -10.0%
75.96
US$138,475 		1,823 -10.0% 75.96 US$138,475
2025-04-17 2025-04-16
S Sale
3,016 -21.2%
28.36
US$85,534 		3,016 -21.2% 28.36 US$85,534
2025-04-16 2025-04-16
PrS Proposed sale
3,016
28.36
US$85,534 		3,016 28.36 US$85,534
2026-01-16 2025-01-16
PrS Proposed sale
1,823
76.23
US$138,964 		1,823 76.23 US$138,964
2020-09-24 2020-09-22
S Sale
720 -1.4%
18.12
US$13,046 		720 -1.4% 18.12 US$13,046
2020-03-25 2020-03-23
S Sale
779 -1.5%
11.75
US$9,153 		779 -1.5% 11.75 US$9,153